mHealth Technologies for Heart Failure
(iCardia4HF Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two mobile health technologies to help individuals with chronic heart failure manage their condition more effectively. One treatment, MyApps, uses health apps and devices to track and manage heart health. The other, Text4HF, sends personalized text messages to encourage better self-care habits. Researchers aim to determine if these tools, alone or combined, can reduce hospitalizations and improve daily management of heart failure. Individuals with Stage C heart failure, currently managing their condition with medication and having had recent heart-related hospital stays, might be suitable for this trial. As a Phase 2/3 trial, this research measures the treatment's effectiveness in an initial, smaller group and represents the final step before FDA approval, offering participants a chance to contribute to advancing heart failure care.
Do I need to stop my current medications for this trial?
The trial does not specify if you need to stop your current medications. However, it mentions that participants must be actively treated with oral loop diuretics for chronic heart failure, so you may need to continue those.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that both the MyApps and Text4HF programs are generally safe for people with heart failure. Studies have found that using mobile health apps and devices, like MyApps, is usually easy for people to manage. These tools help track and manage heart health without major issues. Research on similar apps has shown they can reduce risks without causing significant side effects.
The Text4HF program, which sends personalized text messages to encourage better self-care, has also been tested in other studies. These studies found it to be a safe way to support heart health by helping people adhere to their self-care routines, with no major safety concerns.
Using MyApps and Text4HF together is also considered safe. Early findings suggest this combined approach works well and is user-friendly. Overall, these programs appear to be safe options for managing heart failure.12345Why are researchers excited about this trial's treatments?
Researchers are excited about exploring mHealth technologies like MyApps and Text4HF for heart failure management because these tools offer a fresh approach to self-care. Unlike traditional treatments that mainly focus on medication and regular clinical visits, MyApps uses a combination of health apps and connected devices to help patients monitor and manage their condition daily. Text4HF takes it a step further by providing personalized text messages to boost patients' knowledge and confidence in managing heart failure. Both treatments aim to empower patients with real-time data and support, potentially improving self-management and outcomes in a way that standard care alone might not achieve.
What evidence suggests that this trial's treatments could be effective for heart failure?
Research has shown that mobile health apps like MyApps, which participants in this trial may receive, help people with heart failure take better care of themselves. These apps improve self-care, enabling people to manage their health better and potentially reduce hospital visits. Studies indicate that using these apps and devices can decrease time spent in the hospital and lower the risk of heart-related issues.
Similarly, personalized text messages from programs like Text4HF, another treatment option in this trial, assist heart failure patients by reminding them to follow their care routines. This method encourages healthy habits and helps people maintain consistency in their self-care.
When MyApps and Text4HF are used together, as in one of the trial arms, early research suggests they may be even more effective in enhancing self-care and reducing hospital stays. This combination leverages both technology and personalized messages to promote better health habits.23467Who Is on the Research Team?
Spyros Kitsiou, PhD
Principal Investigator
University of Illinois Chicago
Are You a Good Fit for This Trial?
This trial is for people with chronic heart failure. Participants should be willing to use mobile health apps and devices daily for self-care, and receive tailored text messages aimed at improving their adherence to self-care routines.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Induction
Participants receive the MyApps and/or Text4HF interventions to promote heart failure self-care adherence
Adoption
Continued use of MyApps and/or Text4HF interventions with reduced frequency of text messages
Follow-up
Participants are monitored for maintenance efficacy of interventions and health outcomes
What Are the Treatments Tested in This Trial?
Interventions
- MyApps
- Text4HF
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Illinois at Chicago
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator